Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatesh Pilla-Reddy

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical Pharmacology and Therapeutics|March 20, 2025
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global ConvergenceKellie Reynolds, Xinning Yang, Sheila Annie Peters, et al.
Clinical Pharmacology and Therapeutics|December 4, 2021
Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry PerspectiveNiresh Hariparsad, Diane Ramsden, Kunal Taskar, et al.
Science Translational Medicine|May 1, 2020
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumorsErica Banks, Michael Grondine, Deepa Bhavsar, et al.
Clinical Pharmacology and Therapeutics|January 10, 2018
Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium PerspectiveMohamad Shebley, Punam Sandhu, Arian Emami Riedmaier, et al.
Science Translational Medicine|January 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humansYueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, et al.
Science Advances|June 26, 2018
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor modelsStephen T Durant, Li Zheng, Yingchun Wang, et al.
Journal of Medicinal Chemistry|September 3, 2021
Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> EfficacyWilliam McCoull, Scott Boyd, Martin R Brown, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical Pharmacology and Therapeutics|March 20, 2025
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global ConvergenceKellie Reynolds, Xinning Yang, Sheila Annie Peters, et al.
Clinical Pharmacology and Therapeutics|December 4, 2021
Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry PerspectiveNiresh Hariparsad, Diane Ramsden, Kunal Taskar, et al.
Science Translational Medicine|May 1, 2020
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumorsErica Banks, Michael Grondine, Deepa Bhavsar, et al.
Clinical Pharmacology and Therapeutics|January 10, 2018
Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium PerspectiveMohamad Shebley, Punam Sandhu, Arian Emami Riedmaier, et al.
Science Translational Medicine|January 25, 2022
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humansYueh-Ming Loo, Patrick M McTamney, Rosalinda H Arends, et al.
Science Advances|June 26, 2018
The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor modelsStephen T Durant, Li Zheng, Yingchun Wang, et al.
Journal of Medicinal Chemistry|September 3, 2021
Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> EfficacyWilliam McCoull, Scott Boyd, Martin R Brown, et al.
Pageof 6